Patents by Inventor Robert L. Cavanagh

Robert L. Cavanagh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical methods and compositions
    Patent number: 4339439
    Abstract: Enhanced antiulcer activity is obtained in warm-blooded animals by the concomitant administration of the histamine H.sub.2 -receptor antagonist, etintidine, and the pepsin complexing agent, pepstatin. Concomitant administration of the two entities reduces the amount of etintidine necessary for effective treatment, thereby decreasing its side effect liability.
    Type: Grant
    Filed: January 19, 1981
    Date of Patent: July 13, 1982
    Assignee: Bristol-Myers Company
    Inventors: Joseph P. Buyniski, Robert L. Cavanagh, Maxwell Gordon